PCRX
Pacira BioSciences, Inc. · Healthcare
Director Gary W Pace sold $3.7M of Pacira BioSciences, Inc.
Sold$3,656,226
$30.64Price
119,323Shares
−84%Stake
What PCRX did after the filing
- The stock from Fri, Mar 8 close, $31.41
- −16.9%
- S&P 500, same days
- −2.0%
Measured over 30 trading days, to the Apr 22 close.
Traded Wed, Mar 6. Filed Fri, Mar 8, 12:33 PM ET, during the session. Returns use the Mar 8 close and the Apr 22 close. Not investment advice.